Incidence and predictors of recurrent sick leave in survivors who returned to work after allogeneic hematopoietic cell transplantation

Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–101.

CAS  Article  Google Scholar 

Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, et al. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made? J clin oncol : off j Am Soc Clin Oncol. 2011;29(7):805–13.

Article  Google Scholar 

Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, et al. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. Bone marrow transplantation. 2012.

Kurosawa S, Yamaguchi T, Mori T, Kanamori H, Onishi Y, Emi N, et al. Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia. Bone marrow transplantation. 2015.

Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, et al. Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey. Bone Marrow Transplant. 2019;54(4):611–5.

Article  Google Scholar 

Hamilton BK, Rybicki L, Arai S, Arora M, Cutler CS, Flowers MED, et al. Association of socioeconomic status with chronic graft-versus-host disease outcomes. Biol Blood Marrow Transplant. 2018;24(2):393–9.

Article  Google Scholar 

Morrison EJ, Ehlers SL, Bronars CA, Patten CA, Brockman TA, Cerhan JR, et al. Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2016;22(9):1690–5.

Article  Google Scholar 

Duijts S, Dalton SO, Lundh MH, Horsboel TA, Johansen C. Cancer survivors and return to work: current knowledge and future research. Psychooncology. 2017;26(5):715–7.

Article  Google Scholar 

Endo M, Haruyama Y, Muto G, Imai Y, Mitsui K, Mizoue T, et al. Recurrent sick leave and resignation rates among female cancer survivors after return to work: the Japan sickness absence and return to work (J-SAR) study. BMC Public Health. 2019;19(1):1248.

Article  Google Scholar 

Endo M, Haruyama Y, Muto G, Kiyohara K, Mizoue T, Kojimahara N, et al. Work sustainability among male cancer survivors after returning to work. J Epidemiol. 2018;28(2):88–93.

Article  Google Scholar 

Endo M, Haruyama Y, Takahashi M, Nishiura C, Kojimahara N, Yamaguchi N. Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors. J cancer survivorship : res pract. 2016;10(2):320–9.

Article  Google Scholar 

Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.

Article  Google Scholar 

Mehnert A, de Boer A, Feuerstein M. Employment challenges for cancer survivors. Cancer. 2013;119(Suppl 11):2151–9.

Article  Google Scholar 

Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–301.

Article  Google Scholar 

Steiner JF, Nowels CT, Main DS. Returning to work after cancer: quantitative studies and prototypical narratives. Psychooncology. 2010;19(2):115–24.

Article  Google Scholar 

Takahashi M, Tsuchiya M, Horio Y, Funazaki H, Aogi K, Miyauchi K, et al. Job resignation after cancer diagnosis among working survivors in Japan: timing, reasons and change of information needs over time. Jpn J Clin Oncol. 2018;48(1):43–51.

Article  Google Scholar 

Endo M, Muto G, Imai Y, Mitsui K, Nishimura K, Hayashi K. Predictors of post-cancer diagnosis resignation among Japanese cancer survivors. J cancer survivorship : res pract. 2020;14(2):106–13.

Article  Google Scholar 

Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, et al. Return to work among young adult survivors of allogeneic hematopoietic cell transplantation in the United States. Transplant Cell Ther. 2021;27(8):679.e1-e8.

Article  Google Scholar 

Eriksson L, Wennman-Larsen A, Bergkvist K, Ljungman P, Winterling J. Important factors associated with sick leave after allogeneic haematopoietic stem cell transplantation-a 1-year prospective study. J cancer survivorship : res pract. 2021;15(6):933–41.

Article  Google Scholar 

Kirchhoff AC, Leisenring W, Syrjala KL. Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J cancer survivorship : res pract. 2010;4(1):33–44.

Article  Google Scholar 

Socié G, Mary JY, Esperou H, Robert DV, Aractingi S, Ribaud P, et al. Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2001;113(1):194–201.

Article  Google Scholar 

Kurosawa S, Yamaguchi T, Mori A, Matsuura T, Mori T, Tanaka M, et al. Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. Journal of cancer survivorship : research and practice. 2021.

Khera N, Storer B, Flowers ME, Carpenter PA, Inamoto Y, Sandmaier BM, et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J clin oncol : off j Am Soc Clin Oncol. 2012;30(1):71–7.

Article  Google Scholar 

Sun CL, Francisco L, Kawashima T, Leisenring W, Robison LL, Baker KS, et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood. 2010;116(17):3129–39 (quiz 377).

CAS  Article  Google Scholar 

Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, et al. Comparison of patient-reported outcomes in 5-year survivors who received bone marrow vs peripheral blood unrelated donor transplantation: long-term follow-up of a randomized clinical trial. JAMA Oncol. 2016;2(12):1583–9.

Article  Google Scholar 

Fatobene G, Storer BE, Salit RB, Lee SJ, Martin PJ, Cheng GS, et al. Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation. Haematologica. 2019;104(4):835–43.

CAS  Article  Google Scholar 

Persoon S, Buffart LM, Chinapaw MJM, Nollet F, Frings-Dresen MH, Koning S, et al. Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy. Support Care Cancer. 2019;27(8):2987–97.

CAS  Article  Google Scholar 

Leaflets for job assistance for HCT patients: Japan Society for Transplantation and Cellular Therapy; 2022 [Available from: https://www.jstct.or.jp/modules/facility/index.php?content_id=37.

Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, et al. Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2017.

留言 (0)

沒有登入
gif